Trend

Last Previous Currency Date Chng
1,689.18 1,695.63 USD 26/05/08 -0.38

Terms

Isin LU0112497283
Contract Type N.D.
Currency USD
Class I
Risk Class 5
Assogestioni Category Azionari Salute
Declared Benchmark 100% Nasdaq Biotech Index
Start Date 00/06/27
Advisor Name N.Av.
Fund Asset Under Management 249,6805  at 26/03/31

Performance

Cumulatives
1 month +0.39
Ytd +3.89
1 year +74.71
3 years +61.46
5 years +56.29
Yearly
04/30/2025 +34.21
04/30/2024 +5.95
04/30/2023 +10.81
04/30/2022 -9.34
04/30/2021 -0.02
Rating
N.Av.
Score
N.Av.

Company

Pictet Am (Europe) S.A.
15, Avenue J.F. Kennedy L-1855 - Luxembourg
Tel. +39-02631195100

Costs

Entrance (ACP) Min: 5,0000 - Max: 5,0000
Management 1.2
Reimbursement 1%
Administrative 0,5%
Switch 2%
Tunnel N.D.

Subscription

One Solution
Initial 1000000,0000 USD
Integrative 0,0000 USD
Accumulation Plan
Duration N.Av.
Minimum Payment Unit N.Av.
Initial Payment 1000000,0000

Costs

Entrance (ACP) Min: 5,0000 - Max: 5,0000
Management 1.2
Reimbursement 1%
Administrative 0,5%
Switch 2%
Tunnel N.D.

Performance

Cumulatives
1 day -0.30
1 week +1.96
1 month +0.39
3 months +4.25
6 months +15.85
From the beginning of the year +3.89
1 year +74.71
2 years +43.00
3 years +61.46
4 years +100.14
5 years +56.29
Yearly
04/30/2025 +34.21
04/30/2024 +5.95
04/30/2023 +10.81
04/30/2022 -9.34
04/30/2021 -0.02


Rating
N.Av.
Score
N.Av.

Efficiency Indicators

Sharpe 1 year 2.1632
Benchmark 1 year N.Av.
Sharpe 3 years 0.6853
Benchmark 3 years N.Av.
Sharpe 5 years 0.3616
Benchmark 5 years N.Av.
Sortino 1 year 7.462
Benchmark 1 year N.Av.
Sortino 3 years 1.2033
Benchmark 3 years N.Av.
Sortino 5 years 0.5672
Benchmark 5 years N.Av.

Absolute

Standard Volatility
1 year +21.90
3 years +23.59
5 years +22.29
Negative Volatility
1 year +6.35
3 years +13.43
5 years +14.21

Benchmark

Standard Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Negative Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Updated Monthly - 26/04/30

Relative

Sharpe 0.6853
Sortino 1.2033
Bull Market +12.60
Bear Market -2.62
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Three years data
Risk Class 5

General

  1 year 17,918 3 years 15,839 5 years 14,143
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 17,918
6,285
  
+59.00
3 years 15,839
3,269
  
+63.57
5 years 14,143
7,891
  
+45.31
Performance
6,285 +59.00 3,269 +63.57 7,891 +45.31
Total Volatility
1 year 17,918
20,761
  
+21.90
3 years 15,839
16,873
  
+23.59
5 years 14,143
13,816
  
+22.29
Total Volatility
20,761 +21.90 16,873 +23.59 13,816 +22.29
Negative Volatility
1 year 17,918
17,195
  
+6.35
3 years 15,839
16,582
  
+13.43
5 years 14,143
13,851
  
+14.21
Negative Volatility
17,195 +6.35 16,582 +13.43 13,851 +14.21
Sharpe Index
1 year 17,918
17,206
  
+2.16
3 years 15,839
10,876
  
+0.69
5 years 14,143
10,963
  
+0.36
Sharpe Index
17,206 +2.16 10,876 +0.69 10,963 +0.36
Sortino Index
1 year 17,918
13,700
  
+7.46
3 years 15,839
9,618
  
+1.20
5 years 14,143
10,929
  
+0.57
Sortino Index
13,700 +7.46 9,618 +1.20 10,963 +0.57

By Category

  1 year 17,918 3 years 15,839 5 years 14,143
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 17,918
52
  
+59.00
3 years 15,839
59
  
+63.57
5 years 14,143
56
  
+45.31
Performance
52 +59.00 59 +63.57 56 +45.31
Total Volatility
1 year 17,918
70
  
+21.90
3 years 15,839
64
  
+23.59
5 years 14,143
61
  
+22.29
Total Volatility
70 +21.90 64 +23.59 61 +22.29
Negative Volatility
1 year 17,918
58
  
+6.35
3 years 15,839
61
  
+13.43
5 years 14,143
57
  
+14.21
Negative Volatility
58 +6.35 61 +13.43 57 +14.21
Sharpe Index
1 year 17,918
62
  
+2.16
3 years 15,839
65
  
+0.69
5 years 14,143
56
  
+0.36
Sharpe Index
62 +2.16 65 +0.69 56 +0.36
Sortino Index
1 year 17,918
60
  
+7.46
3 years 15,839
63
  
+1.20
5 years 14,143
56
  
+0.57
Sortino Index
60 +7.46 63 +1.20 56 +0.57

Foreign Funds - Pictet-Biotech-I $: Performance, Terms, Fees, Risk, Rating


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.